Quipt Home Medical Announces Cooperation Agreement With Kanen Wealth Management

Core Viewpoint - Quipt Home Medical Corp. has entered into a cooperation agreement with Kanen, which includes the withdrawal of Kanen's intent to solicit proxies for director candidates at the upcoming annual general meeting [1][9]. Group 1: Cooperation Agreement Details - Kanen has agreed to withdraw its notice of intent to solicit proxies in support of four director candidates opposing the Company's recommended candidates [1][9]. - The Company’s Board has granted Kanen certain access rights as long as Kanen maintains at least 3.5% beneficial ownership of the Company's outstanding shares [1][2]. - A new committee will be established by the Company to review and analyze Kanen's recommendations related to corporate governance and operations [2]. Group 2: Statements from Leadership - Mark Greenberg, Lead Independent Director, expressed gratitude for Kanen's constructive discussions and emphasized the importance of ongoing engagement for long-term growth [3]. - David Kanen, President and CEO of Kanen, acknowledged the Company's willingness to engage and highlighted the formation of the new committee as a significant step towards unlocking long-term value [3]. Group 3: Company Overview - Quipt Home Medical provides in-home monitoring and disease management services, focusing on end-to-end respiratory solutions for patients in the U.S. healthcare market [5]. - The Company aims to expand its offerings to manage various chronic diseases, with a primary objective of creating shareholder value through a broader range of services [5].